Home » Our Team » Lauren Laimon

Lauren Laimon

Project Director

Lauren Laimon is a Project Director with 19 years of clinical trials experience. Currently, she leads the coordinating center for the NICHD Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings (PATC3H) program. PATC3H aims to generate the needed scientific innovation that will yield effective public health interventions for 10- to 24-year-old adolescents and young adults affected by HIV in resource-limited settings in Brazil and sub-Saharan Africa.

Ms. Laimon has also managed a complex pharma study for a treatment for severe COVID-19. She was responsible for the recruitment and readying of sites across the United States and coordinated day-to-day operations including the oversight of regulatory, site monitoring, data collection/analysis, and safety activities.

Ms. Laimon has served on numerous education and training panels as well as promotion and public awareness panels. She has created educational materials and has been responsible for developing and testing informational products for a national health communications campaign. In addition, she has extensive experience developing websites, planning major conferences, and has assisted in the development and implementation of various in-person and web-related trainings.

Selected Publications and Presentations

  1. Mussi-Pinhata, M.M., Ward, S., Laimon, L., Pelton, S.I., Canniff, J., Golner, A., Bone, F., Newton, L., Muresan, P., Fenton, T., Johnson, M.J., Johnson, M.J., João, E.C., Santos, B.R., Pilotto, J.H., Oliveira, R.H., Pinto, J.A., Dal Bó, A., Kreitchmann, R., Chakhtoura, N., Duarte, G., and Weinberg, A. (2022). Effect of maternal vaccination of PCV-10, PPV-23 or placebo on the immunogenicity of PCV-10 in HIV-exposed uninfected infants: A randomized clinical trial. Clin Infect Dis. doi: 10.1093/cid/ciac026 PMID: 35037049
  2. Duarte, G., Muresan, P., Ward, S., Laimon, L., Pelton, S.I., Canniff, J., Golner, A., Bone, F., Newton, L., Fenton, T., Coutinho, C.M., João, E.C., Santos, B.R., Pilotto, J.H., Oliveira, R.H., Pinto, J.A., Machado, E.S., Kreitchman, R., Chakhtoura, N., Mussi-Pinhata, M.M., Weinberg, A., and Team, N.P.S. (2021). Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV. Journal of Infectious Diseases. doi: 10.1093/infdis/jiab567 PMID: 34791324
  3. Tucker, J.D., Iwelunmor, J., Abrams, E., Donenberg, G., Wilson, E.C., Blachman-Demner, D., Laimon, L., Taiwo, B.O., Kuhns, L.M., John-Stewart, G.C., Kohler, P., Subramanian, S., Ayieko, J., Gbaja-BIamila, T., Oladele, D., Obiezu-Umeh, C., Chima, K.P., Jalil, E.M., Falcao, J., Ezechi, O.C., and Kapogiannis, B.G. (2021). Accelerating adolescent HIV research in low-income and middle-income countries: Evidence from a research consortium. AIDS, 35(15), 2503-2511. doi: 10.1097/QAD.0000000000003049 PMID: 34870930
  4. Weinberg, A., Muresan, P., Laimon, L., Pelton, S.I., Goldblatt, D., Canniff, J., Zimmer, B., Bone, F., Newton, L., Fenton, T., Kiely, J., Johnson, M.J., João, E.C., Santos, B.R., Machado, E.S., Pinto, J.A., Chakhtoura, N., Duarte, G., and Mussi-Pinhata, M.M. (2021). Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial. The Lancet. HIV, 8(7), e408-e419. doi: 10.1016/s2352-3018(20)30339-8 PMID: 33915104 PMCID: PMC8249331
  5. João, E.C., Morrison, R.L., Shapiro, D.E., Chakhtoura, N., Gouvèa, M.I.S., de Lourdes, B.T.M., Fuller, T.L., Mmbaga, B.T., Ngocho, J.S., Njau, B.M., Violari, A., Mathiba, R., Essack, Z., Pilotto, J.H.S., Moreira, L.F., Rolon, M.J., Cahn, P., Prommas, S., Cressey, T.R., Chokephaibulkit, S., Werarak, P., Laimon, L., Hennessy, R., Frenkel, L.M., Anthony, P., Best, B.M., Siberry, G.K., and Mirochnick, M. (2020). Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial. The Lancet. HIV, 7(5), e322-e331. doi: 10.1016/s2352-3018(20)30038-2 PMID: 32386720 PMCID: PMC7323582


MS, Clinical Research Administration, George Washington University

BBA, James Madison University